Beyond Approval Delays: What 2026 FDA Complete Response Letters Reveal About the Evolving Role of Pharmacovigilance
Complete Response Letters (CRLs) remain one of the most informative, yet often underutilized, sources of regulatory intelligence available to the pharmaceutical industry. Although typically viewed through the lens of delayed approvals, these letters provide valuable insight into the U.S. Food and Drug Administration’s evolving expectations regarding product quality, clinical evidence, benefit-risk assessment, and patient safety. […]
Is the FDA Replacing FAERS?
If you’ve been following recent developments in Pharmacovigilance, you’ve probably come across headlines suggesting that the U.S. Food and Drug Administration is replacing the FDA Adverse Event Reporting System (FAERS). For many Drug Safety professionals, that immediately raises an important question: Does this change the way we practice Pharmacovigilance? The short answer is yes, the […]
Introduction
Your Questions, My Thoughts: Navigating the PV Landscape The inbox at MediPharmSolutions has been buzzing lately. From students finishing their certifications to seasoned professionals looking for a pivot, the “Mentor Circle” is alive with curiosity. Pharmacovigilance (PV) is more than just data entry; it’s the heartbeat of patient safety. To showcase some of the questions […]
Off-Label Drug Use: Why Safety Monitoring Matters More Than Ever
This practice, known as off-label drug use, has become increasingly common across multiple therapeutic areas. While off-label prescribing can provide important treatment options for patients with unmet medical needs, it also introduces significant challenges for Drug Safety and Pharmacovigilance professionals responsible for monitoring medication safety after market approval. Basic Knowledge of Off-Label Drug Use Off-label […]
“How did the interview go?”
“How did the interview go?” — The question that stings… until it teaches you everything Last week, one of my mentees—let’s call her Priya—walked out of what she thought was a strong interview for a Drug Safety Associate role. She had done everything right on paper. ✔ Strong academic background ✔ Hands-on Pharmacovigilance exposure ✔ […]
Upcoming Trends in Drug Safety with AI/ML
The drug safety landscape is undergoing its most profound transformation in a generation. AI agents, large language models, and real-world data pipelines are reshaping how we detect, assess, and communicate safety signals — and the professionals who thrive will be those who blend deep domain expertise with technological fluency. Why Now? Pharmacovigilance was built on […]